Abstract

ObjectivesDespite several effective targeted therapies, biomarkers that predict whether a patient with psoriatic arthritis (PsA) will respond to a particular treatment are currently lacking.MethodsWe analysed proteomics data from serum samples...

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
POS1545 MODULATION OF SERUM BIOMARKERS IN PATIENTS WITH PSA TREATED WITH RISANKIZUMAB IN THE PHASE 3 KEEPSAKE 2 STUDY
B Ravishankar ... Y Fang
-
B Ravishankar, et. al.B Ravishankar ... Y Fang
30 May 2023
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis.
Alexa P Kollmeier ... Xie L Xu
Arthritis & Rheumatology | VOL. 76
Alexa P Kollmeier, et. al.Alexa P Kollmeier ... Xie L Xu
04 Mar 2024
British Association of Dermatologists’ guidelines for biologic interventions for psoriasis 2009
C.H Smith ... A.Y Finlay
The British journal of dermatology | VOL. 161
C.H Smith, et. al.C.H Smith ... A.Y Finlay
20 Oct 2009
Interleukin-17 inhibitor, is it safer than tumor necrosis factor inhibitor?
Jinxian Huang ... James C‐C Wei
APLAR Journal of Rheumatology | VOL. 24
Jinxian Huang, et. al.Jinxian Huang ... James C‐C Wei
01 Jul 2021
View more papers

More From: RMD Open

Paper Title
Journal
Date
Author
Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)
Laura Pina Vegas ... Pascal Claudepierre
RMD open | VOL. 10
Laura Pina Vegas, et. al.Laura Pina Vegas ... Pascal Claudepierre
07 Aug 2024
Effectiveness of methotrexate and bridging glucocorticoids with or without early introduction of a 6-month course of etanercept in early RA: results of the 2-year, pragmatic, randomised CareRA2020 trial
Delphine Bertrand ... Patrick Verschueren
RMD open | VOL. 10
Delphine Bertrand, et. al.Delphine Bertrand ... Patrick Verschueren
07 Aug 2024
Is there a role for novel supplements in the management of fatigue in rheumatic diseases?
Thomas Khoo ... Hector Chinoy
RMD Open | VOL. 10
Thomas Khoo, et. al.Thomas Khoo ... Hector Chinoy
27 Jul 2024
Sensitivity to change of structural outcomes in axial spondyloarthritis after 10 years of follow up. Data from the DESIR cohort
Clementina López-Medina ... Maxime Dougados
RMD Open | VOL. 10
Clementina López-Medina, et. al.Clementina López-Medina ... Maxime Dougados
25 Jul 2024
View more papers